Product NDC: | 55111-399 |
Proprietary Name: | Lansoprazole |
Non Proprietary Name: | lansoprazole |
Active Ingredient(s): | 30 mg/1 & nbsp; lansoprazole |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-399 |
Labeler Name: | Dr.Reddy's Laboratories Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091269 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101015 |
Package NDC: | 55111-399-79 |
Package Description: | 1 BLISTER PACK in 1 CARTON (55111-399-79) > 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK |
NDC Code | 55111-399-79 |
Proprietary Name | Lansoprazole |
Package Description | 1 BLISTER PACK in 1 CARTON (55111-399-79) > 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK |
Product NDC | 55111-399 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lansoprazole |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20101015 |
Marketing Category Name | ANDA |
Labeler Name | Dr.Reddy's Laboratories Ltd. |
Substance Name | LANSOPRAZOLE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |